Telerehabilitation With Digital Technologies for the Continuum of Care of Stroke Patients
StrokeHomeFit4
2 other identifiers
interventional
160
1 country
13
Brief Summary
The goal of the pragmatic study is to evaluate the effectiveness of a home-based telerehabilitation protocol for patients with post-stroke disabilities, compared to a home-based educational program. The main question it aims to answer is: Is home-based neuromotor and cognitive rehabilitation using digital tools more effective than a traditional educational program for improving static and dynamic balance in patients with subacute and chronic stroke? Researchers will compare the outcome (Berg Balance Scale) measured at baseline with the outcome after treatment to test its effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started May 2025
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedStudy Start
First participant enrolled
May 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedMay 30, 2025
April 1, 2025
12 months
May 9, 2025
May 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in the Berg Balance Scale (BBS)
The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. It does not include the assessment of gait.
Baseline; within 7 days after the end of the 6-week observation/rehabilitation period
Secondary Outcomes (17)
Fugl-Meyer Assessment for the upper extremities - motor function
Baseline; within 7 days after the end of the 6-week observation/rehabilitation period
Fugl-Meyer Assessment for the upper extremities - sensory function
Baseline; within 7 days after the end of the 6-week observation/rehabilitation period
Fugl-Meyer Assessment for the lower extremities - motor function
Baseline; within 7 days after the end of the 6-week observation/rehabilitation period
Fugl-Meyer Assessment for the lower extremities - sensory function
Baseline; within 7 days after the end of the 6-week observation/rehabilitation period
Modified Rivermead Motricity Index
Baseline; within 7 days after the end of the 6-week observation/rehabilitation period
- +12 more secondary outcomes
Other Outcomes (13)
premorbid Modified Rankin Scale
Baseline
Montreal Cognitive Assessment Scale
Baseline
Timed Up and Go
Baseline
- +10 more other outcomes
Study Arms (2)
Treatment with Digital Tools
EXPERIMENTALThe experimental treatment involves home-based telerehabilitation protocols utilizing digital tools. Patients will perform task-oriented activities aimed at improving balance through standing and/or seated exercises under both static and dynamic conditions. Exercise complexity will be progressively adapted and personalized based on the patient's performance, improvement trajectory, and instrumental feedback from the digital system. All devices must have a CE mark for medical devices and be used according to the manufacturer's specifications.
Educational Program
ACTIVE COMPARATORPatients in the Control Group will follow a self-guided educational program supported by printed materials outlining daily living activities to be performed at home.
Interventions
Patients will undergo a 6-week remote telerehabilitation program. The recommended frequency of treatment is a minimum of 3 sessions per week, but patients may adjust the schedule in agreement with their assigned therapist. If a patient is unable to complete at least 18 sessions due to clinical reasons, they will be considered as a dropout. Moreover, one session per week will be conducted synchronously, with the therapist remotely supervising the patient's activities in real time, while the remaining sessions will be asynchronous, allowing the patient to complete the exercises independently.
Patients will be monitored over a six-week period through weekly phone calls to assess their progress and overall condition. Additionally, participants are required to maintain an activity diary to document their engagement with the prescribed activities.
Eligibility Criteria
You may qualify if:
- Diagnosis of first ischemic or hemorrhagic stroke verified by Computed Axial Tomography or MRI.
- Age greater than 18 years.
- Latency since the event: a) greater than 3 months and less than or equal to 6 months; b) greater than 6 months and less than 24 months.
- Ability to perform the Timed Up and Go Test.
You may not qualify if:
- Unstable clinical conditions.
- Behavioral/cognitive disorders that prevent adequate patient compliance with the study (severe cognitive impairment, Montreal Cognitive Assessment\<17.5).
- Severe visual impairment that cannot be corrected by lenses, preventing the patient from performing treatment with digital instruments.
- Refusal to sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Don Carlo Gnocchi Onluslead
- Istituti Clinici Scientifici Maugeri SpAcollaborator
- IRCCS National Neurological Institute "C. Mondino" Foundationcollaborator
- Ospedale Policlinico San Martinocollaborator
- C.O.T. Cure Ortopediche Traumatologiche S.p.A.collaborator
- Università di Paviacollaborator
- Scuola Superiore Sant'Anna di Pisacollaborator
- Campus Bio-Medico Universitycollaborator
Study Sites (13)
Fondazione Don Carlo Gnocchi, Centro Gala
Acerenza, Italy
IRCCS Istituti Clinici Scientifici Maugeri
Bari, Italy
IRCCS Ospedale Policlinico San Martino
Genova, Italy
COT, Cure Ortopediche Traumatologiche, Istituto Clinico Polispecialistico
Messina, Italy
Fondazione Don Carlo Gnocchi, IRCCS Santa Maria Nascente
Milan, Italy
IRCCS Istituti Clinici Scientifici Maugeri
Milan, Italy
IRCCS Istituti Clinici Scientifici Maugeri
Montescano, Italy
IRCCS Fondazione Mondino
Pavia, Italy
Fondazione Don Carlo Gnocchi, Centro Santa Maria della Provvidenza
Rome, Italy
Fondazione Don Carlo Gnocchi, Centro Santa Maria al Mare
Salerno, Italy
Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo
Sant'Angelo dei Lombardi, Italy
IRCCS Istituti Clinici Scientifici Maugeri
Telese Terme, Italy
Fondazione Don Carlo Gnocchi, Polo specialistico riabilitativo
Tricarico, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Irene G Aprile, MD, PhD
IRCCS Fondazione Don Carlo Gnocchi
- PRINCIPAL INVESTIGATOR
Christian Lunetta
IRCCS Istituti Clinici Scientifici Maugeri
- PRINCIPAL INVESTIGATOR
Roberto De Icco
IRCCS Fondazione Mondino
- PRINCIPAL INVESTIGATOR
Carlo Trompetto
IRCCS Ospedale Policlinico San Martino
- PRINCIPAL INVESTIGATOR
Ennio Ferlazzo
COT Istituto Clinico Polispecialistico
- PRINCIPAL INVESTIGATOR
Silvana Quaglini
Università di Pavia
- PRINCIPAL INVESTIGATOR
Giuseppe Turchetti
Università Sant'Anna di Pisa
- PRINCIPAL INVESTIGATOR
Leandro Pecchia
Campus Bio-Medico University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2025
First Posted
May 18, 2025
Study Start
May 20, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
May 30, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning six months after the publication, with no end date.
- Access Criteria
- Access will be provided to the general scientific community and any interested researchers, for any type of analysis or secondary research use. The data will be made available on a public data-sharing platform such as Zenodo, or Figshare.
De-identified individual participant data (IPD) that underlie the results reported in the publication will be shared.